Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
Context | Citation |
---|---|
Increases Blautia wexlerae - : bifidobacterium |
📓
Effect of <i>Lactobacillus rhamnosus</i> HN001 and <i>Bifidobacterium longum</i> BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study. World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 15 Pages: 2696-2704 Pub: 2017 Apr 21 Epub: Authors Toscano M , De Grandi R , Stronati L , De Vecchi E , Drago L , Html Article Publication |
Increases Blautia wexlerae - : bifidobacterium |
📓
Bifidobacterium longum BB536 alleviated upper respiratory illnesses and modulated gut microbiota profiles in Malaysian pre-school children. Beneficial microbes (Benef Microbes ) Vol: 9 Issue 1 Pages: 61-70 Pub: 2018 Jan 29 Epub: 2017 Oct 25 Authors Lau AS , Yanagisawa N , Hor YY , Lew LC , Ong JS , Chuah LO , Lee YY , Choi SB , Rashid F , Wahid N , Sugahara H , Xiao JZ , Liong MT , Publication |
Increases Blautia wexlerae - : bifidobacterium |
👶
Bifidobacterium animalis subsp. lactis BB-12 Has Effect Against Obesity by Regulating Gut Microbiota in Two Phases in Human Microbiota-Associated Rats. Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 811619 Pub: 2021 Epub: 2022 Jan 10 Authors Mao K , Gao J , Wang X , Li X , Geng S , Zhang T , Sadiq FA , Sang Y , Publication |
Decreases Blautia wexlerae - : bifidobacterium |
👶
Evaluation of the therapeutic effect and dose-effect of Bifidobacterium breve on the primary Clostridioides difficile infected mice. Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 105 Issue 24 Pages: 9243-9260 Pub: 2021 Dec Epub: 2021 Nov 9 Authors Yang J , Yang H , Publication |
0 π | π’ 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]